Combination of azacitidine, venetoclax and ruxolitinib in blast phase myeloproliferative neoplasms.
Systchenko T, Chomel JC, Gallego-Hernanz P, Moya N, Desmier D, Maillard N, Bobin A, Vonfeld M, Gardeney H, Cayssials E E, Torregrosa J.
Systchenko T, et al. Among authors: chomel jc.
Br J Haematol. 2023 Jul;202(2):284-288. doi: 10.1111/bjh.18853. Epub 2023 May 14.
Br J Haematol. 2023.
PMID: 37183377